Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
40 pending office actions • 28 clients • 39 examiners • 31 art units • 0 of 40 (0%) have an AI response strategy ready
PORTER WRIGHT MORRIS & ARTHUR, LLP has 41 pending office actions in Biotechnology & Pharmaceuticals and 1826 career applications. The application history provides substantial context for the firm’s current biotechnology and pharmaceutical docket.
The resolved allowance rate is 85.0%, and the average is 3.35 office actions per allowance. The data indicates that most resolved matters reached allowance, typically after several office-action events. Clients can use this profile to assess a practice with broad application experience and a prosecution process that commonly involves continued examination work before a matter is allowed.
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 7 (18%) |
| §103 only | 9 (22%) |
| §102 only | 1 (2%) |
| §112 only | 3 (8%) |
| Double-patenting + other | 3 (8%) |
| Multi-statute (no §101) | 16 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOEKSTRA, JEFFREY GERBEN | 2 | 56.1% | +39.8% |
| DEERY, ERIN LEAH | 1 | 58.4% | +48.7% |
| SHANSKE, JASON D | 1 | 76.4% | +14.1% |
| NGUYEN, LOAN T | 1 | 64.2% | +23.2% |
| MANGIALASCHI, TRACY | 1 | 75.6% | +27.0% |
| ARCORIA, PAUL JOSEPH | 1 | 100.0% | +0.0% |
| MISHRA, DEEPA | 1 | 28.9% | +35.5% |
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
| BADAWI, ANGIE M | 1 | 58.8% | +36.1% |
| TICHY, JENNIFER M.H. | 1 | 64.6% | +34.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18863395 | SELECTIVE DOPAMINE INCREASE | ARCORIA, PAUL JOSEPH | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17925238 | IMPROVEMENTS TO APPARATUS AND METHODS FOR MANIPULATING MICRODROPLETS | XU, QING | 42d overdue |
| 18246705 | PROBE-GUIDE FOR IDENTIFYING AND HARVESTING A BIOPSY | HOEKSTRA, JEFFREY GERBEN | 38d overdue |
| 17534548 | Analyte Detection Method Employing Concatemers | RAYMONDA, MATTHEW HAROLD | 2d overdue |
| 19061380 | Toilet Training Seat | DEERY, ERIN LEAH | — |
| 19056408 | TWO-PIECE THREADED FASTENER ASSEMBLY | SHANSKE, JASON D | — |
| 19053339 | SYSTEM AND METHOD FOR AUTOMATICALLY IDENTIFYING IMPORTANT NEWS ACROSS LARGE DATASETS | NGUYEN, LOAN T | — |
| 18869406 | AUTOMATED IMAGE INFERENCE FROM WHOLE-BODY MEDICAL IMAGES | MANGIALASCHI, TRACY | — |
| 18915716 | METHODS FOR PREDICTING AUTOIMMUNITY POST GENE THERAPY | MISHRA, DEEPA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18246705 | PROBE-GUIDE FOR IDENTIFYING AND HARVESTING A BIOPSY | HOEKSTRA, JEFFREY GERBEN | 38d overdue |
| 19061380 | Toilet Training Seat | DEERY, ERIN LEAH | — |
| 19056408 | TWO-PIECE THREADED FASTENER ASSEMBLY | SHANSKE, JASON D | — |
| 19053339 | SYSTEM AND METHOD FOR AUTOMATICALLY IDENTIFYING IMPORTANT NEWS ACROSS LARGE DATASETS | NGUYEN, LOAN T | — |
| 18869406 | AUTOMATED IMAGE INFERENCE FROM WHOLE-BODY MEDICAL IMAGES | MANGIALASCHI, TRACY | — |
| 18915716 | METHODS FOR PREDICTING AUTOIMMUNITY POST GENE THERAPY | MISHRA, DEEPA | — |
| 18841078 | NON-CONTACT OXYGEN SATURATION ESTIMATION USING AMBIENT LIGHT | HOEKSTRA, JEFFREY GERBEN | — |
| 18775990 | MULTI-REFERENCE EVENT SUMMARIZATION | BADAWI, ANGIE M | — |
| Art Unit | Apps |
|---|---|
| 1797 | 3 |
| 1798 | 3 |
| 3791 | 2 |
| 1653 | 2 |
| 1758 | 2 |
| 1684 | 2 |
| 3754 | 1 |
| 3614 | 1 |
| 2165 | 1 |
| 1629 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19061380 | Toilet Training Seat | Mykidzy LLC | DEERY, ERIN LEAH | 3754 | §103§112 | Non-Final OA | — | Pending | Feb 24, 2025 |
| 19056408 | TWO-PIECE THREADED FASTENER ASSEMBLY | Tite-Spot, LLC | SHANSKE, JASON D | 3614 | §102§103Other | Non-Final OA | — | Pending | Feb 18, 2025 |
| 19053339 | SYSTEM AND METHOD FOR AUTOMATICALLY IDENTIFYING IMPORTANT NEWS ACROSS LARGE DATASETS | Primer Technologies, Inc. | NGUYEN, LOAN T | 2165 | §101§103§112 | Final Rejection | — | Pending | Feb 13, 2025 |
| 18869406 | AUTOMATED IMAGE INFERENCE FROM WHOLE-BODY MEDICAL IMAGES | Carcinoquant AB | MANGIALASCHI, TRACY | §101§103 | Non-Final OA | — | Pending | Nov 26, 2024 | |
| 18863395 | SELECTIVE DOPAMINE INCREASE | Sobrera Pharma AB | ARCORIA, PAUL JOSEPH | 1629 | §103 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18915716 | METHODS FOR PREDICTING AUTOIMMUNITY POST GENE THERAPY | Children'S Hospital Medical Center | MISHRA, DEEPA | 1657 | §101§103§112 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18841078 | NON-CONTACT OXYGEN SATURATION ESTIMATION USING AMBIENT LIGHT | Detectivio AB | HOEKSTRA, JEFFREY GERBEN | 3791 | §101§102§112 | Non-Final OA | — | Pending | Aug 23, 2024 |
| 18781181 | USE OF DEXTRAN SULFATE | Tx Medic AB | BERRY, LAYLA D | 1693 | §103DP | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18775990 | MULTI-REFERENCE EVENT SUMMARIZATION | Primer Technologies, Inc. | BADAWI, ANGIE M | 2179 | §101§102§103 | Non-Final OA | — | Pending | Jul 17, 2024 |
| 18667066 | BACTERIA CLASSIFICATION AND ANALYSIS | Sysmex Corporation | TICHY, JENNIFER M.H. | 1653 | §102§112 | Non-Final OA | — | Pending | May 17, 2024 |
| 18681294 | TAMPON INSERTION DEVICE AND METHOD | Tina Holdings, LLC | WRUBLESKI, MATTHEW JAMES | 3781 | §102§103DP | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18291635 | CONTROLLED DRUG RELEASE MATERIAL | Aduro Material AB | RAO, SAVITHA M | 1691 | §103 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18578381 | DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT | Children'S Hospital Medical Center | AMICK, THOMAS RUSSE | 1638 | §102 | Non-Final OA | — | Pending | Jan 11, 2024 |
| 18577441 | IMPROVEMENTS IN OR RELATING TO A METHOD OR AN APPARATUS FOR DETECTING AN INTERACTION BETWEEN A BIOLOGICAL ENTITY AND A MOLECULE | Lightcast Discovery Ltd. | SODERQUIST, ARLEN | 1797 | §102§103§112 | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18573570 | NEW USE OF MONENSIN | Marco Maccarana | VALLE, ERNESTO | 1623 | §102§103§112 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18572370 | PREDICTING CANCER RELAPSE | Arocell AB | FONTAINHAS, AURORA M | 1675 | §101§102§103§112DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18556408 | ADENOVIRUS FOR TREATMENT OF CANCER | Elicera Therapeutics AB | CANDELARIA, JULIANA IRENE | 1634 | §102§103§112 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18556183 | COMPOSITIONS AND METHODS FOR CELL-FREE NUCLEIC ACID ISOLATION | Simsen Diagnostics AB | PHAM, KHAI QUYNH TIEN | 1682 | §102§103 | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18282396 | METHOD OF SELECTING CELLS | Lightcast Discovery Ltd. | LUSI, ELLIS FOLLETT | 1636 | §112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18263146 | METHOD OF PROVIDING BROAD-SPECTRUM RESISTANCE TO PLANTS, AND PLANTS THUS OBTAINED | Naga Charan Konakalla | ORDAZ, CHRISTIAN JOSE | 1663 | §112 | Final Rejection | 97d overdue | Pending | Jul 27, 2023 |
| 18252813 | REFINED USES OF GABA A RECEPTOR MODULATORS IN TREATMENT OF FRAGILE X SYNDROME | Children'S Hospital Medical Center | WHITE, DENNIS MICHAEL | 1758 | §102§103Other | Final Rejection | — | Pending | May 12, 2023 |
| 18030130 | IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS | Lightcast Discovery Ltd. | CHIU, MAY LEUNG | 1758 | §103 | Final Rejection | 27d | Pending | Apr 04, 2023 |
| 18030132 | IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS | Lightcast Discovery Ltd. | MUI, CHRISTINE T | 1797 | §103§112 | Final Rejection | — | Pending | Apr 04, 2023 |
| 18030136 | IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS | Lightcast Discovery Ltd. | HERON, VELVET ELIZABETH | 1798 | §102§103 | Final Rejection | — | Pending | Apr 04, 2023 |
| 18246705 | PROBE-GUIDE FOR IDENTIFYING AND HARVESTING A BIOPSY | Fluolink AB | HOEKSTRA, JEFFREY GERBEN | 3791 | §102§103§112 | Final Rejection | 38d overdue | Pending | Mar 27, 2023 |
| 18172388 | CARTRIDGE AND METHOD OF ANALYSING A BIOLOGICAL SAMPLE | Sysmex Corporation | KWAK, DEAN P | 1798 | §102§112Other | Non-Final OA | — | Pending | Feb 22, 2023 |
| 18109074 | SYSTEM FOR SYSTEM FOR PREPARING HIGH-PURITY TAURINE AND SALT | Qianjiang Yongan Pharmaceutical Co. Ltd. | KUYKENDALL, ALYSSA LEE | 1774 | §103 | Non-Final OA | 79d overdue | Pending | Feb 13, 2023 |
| 18040074 | CALCIUM-DEFICIENT SILICATE-SUBSTITUTED CALCIUM PHOSPHATE APATITE COMPOSITIONS AND METHODS | Ossdsign AB | LIU, TRACY | 1614 | §103 | Non-Final OA | 70d | Pending | Jan 31, 2023 |
| 18002526 | Functionalized Blood Sampling Device and Method for PEth Measurement | Capitainer AB | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103 | Final Rejection | 147d overdue | Pending | Dec 20, 2022 |
| 18067211 | SENSOR UNIT, MEASURING METHOD AND PRODUCTION METHOD | Presens Precision Sensing GmbH | GERIDO, DWAN A | 1797 | §102§103§112 | Non-Final OA | — | Pending | Dec 16, 2022 |
| 18001080 | LYMPHOCYTE CLONALITY DETERMINATION | Simsen Diagnostics AB | YOUNG, BRIAN ELLIS | 1684 | §103DP | Final Rejection | 15d | Pending | Dec 08, 2022 |
| 17925238 | IMPROVEMENTS TO APPARATUS AND METHODS FOR MANIPULATING MICRODROPLETS | Lightcast Discovery Ltd. | XU, QING | 1656 | §102§103 | Final Rejection | 42d overdue | Pending | Nov 14, 2022 |
| 17958287 | SYSTEM AND METHOD TO ENGINEER USER EXPERIENCE | Cigniti Technologies Limited | MORSHED, HOSSAIN M | 2191 | §101 | Final Rejection | — | Pending | Sep 30, 2022 |
| 17907712 | Multi-Well Plates for Creation of High-Density Arrays of Compartmentalized Cell Cultures for Usage in High Capacity Applications | Cellectricon AB | GIERE, REBECCA M | 1677 | §112 | Non-Final OA | 52d overdue | Pending | Sep 29, 2022 |
| 17794286 | PREDICTING PATIENT SURVIVAL | Arocell AB | DUNN, MCKENZIE A | 1678 | §103 | Non-Final OA | — | Pending | Jul 21, 2022 |
| 17785455 | PLATELET CONCENTRATE CONTROL | Cyteguard AB | CHOWDHURY, TARIFUR RASHID | 2877 | §103 | Final Rejection | — | Pending | Jun 15, 2022 |
| 17767730 | METHOD AND APPARATUS FOR CLINICAL TESTING | Lightcast Discovery Ltd. | AFREMOVA, VERA | 1653 | §103§112 | Non-Final OA | — | Pending | Apr 08, 2022 |
| 17642510 | IN VITRO FERTILISATION (IVF) EMBRYO VIABILITY AND QUALITY ASSAY | UNIVERSITY OF TARTU | BAUSCH, SARAE L | 1699 | §101§102§112 | Final Rejection | — | Pending | Mar 11, 2022 |
| 17534548 | Analyte Detection Method Employing Concatemers | Olink Proteomics AB | RAYMONDA, MATTHEW HAROLD | 1684 | §102§103 | Non-Final OA | 2d overdue | Pending | Nov 24, 2021 |
| 17297112 | EX VIVO ORGAN TREATMENT WITH PEG-PHOSPHOLIPID MOLECULES | Icoat Medical AB | BEHARRY, ZANNA MARIA | 1632 | §103 | Final Rejection | — | Pending | May 26, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial85.0% of resolved applications prosecuted by Porter Wright Morris & Arthur, LLP were allowed, across 1,826 applications in USPTO records.
3.35 office actions per allowed application on average.
40 pending office actions as of October 2026, for 28 clients, before 39 examiners in 31 art units.
